| ");
document.title=document.title+ " ";
arnews[0]="Safe Drug Use After a Natural Disaster "; arnews[0] += "Updated"; arnews[0] += " Publ.Date : Thu, 02 Sep 2010 16:43:00 -0400"; arnews[0] += " "; arnews[1]="Information Regarding Insulin Storage and Switching Between Products in an Emergency "; arnews[1] += "Updated"; arnews[1] += " Publ.Date : Thu, 02 Sep 2010 16:34:00 -0400"; arnews[1] += " "; arnews[2]="New and Generic Drug Approvals "; arnews[2] += "Drug Approval Listing"; arnews[2] += " Publ.Date : Thu, 02 Sep 2010 14:35:00 -0400"; arnews[2] += " "; arnews[3]="Current Drug Shortages "; arnews[3] += "New/Updated Drug Shortages: Etoposide solution for injection 9/2/2010, Morphine Injection (2 mg, 4 mg, 8 mg, and 10 mg) (updated) 9/2/2010, Mitomycin for injection (updated) 9/2/2010, Mexiletine Capsules (150mg, 200mg, and 250mg) (updated) 9/2/2010, Leucovorin Calcium Lyophilized Powder for Injection (updated) 9/2/2010, Haloperidol Decanoate Injection (updated) 9/2/2010, Furosemide Injection 10mg/ml (updated) 9/2/2010, Epinephrine 0.1 mg/mL Emergency Syringes 10 mL LifeShield Abboject syringe with 1.5 inch, 21-gauge needle (NDC 00409-4921-34) (updated) 9/2/2010, Succinylcholine injection (updated) 9/2/2010, Atracurium injection (updated) 9/1/2010, Calcium Chloride Injection (updated) 9/1/2010, Cisplatin injection 1 mg/mL solution (updated) 9/1/2010, Dextrose 50% injection (updated) 9/1/2010, Fabrazyme (agalsidase beta) (updated) 9/1/2010, Technetium Tc99m Generators (updated)8/31/2010, Succinylcholine injection 8/25/2010, Morphine Injection (2 mg, 4 mg, 8 mg, and 10 mg) 8/20/2010, Cisplatin injection 1 mg/mL solution 8/18/2010, Technetium Tc99m Generators (updated) 8/16/2010, Naloxone Injection (updated) 8/16/2010, Vecuronium Injection (updated) 8/10/2010, Mitomycin for injection (updated) 8/10/2010, Haloperidol Decanoate Injection (updated) 8/10/2010, Furosemide Injection 10mg/ml (updated) 8/10/2010, Epinephrine 0.1 mg/mL Emergency Syringes 10 mL LifeShield Abboject syringe with 1.5 inch, 21-gauge needle (NDC 00409-4921-34) (updated) 8/5/2010, Dextrose 50% injection (updated) 8/5/2010, Calcium Chloride Injection (updated) 8/5/2010, Foscarnet sodium 24 mg/mL injection 8/5/2010, Sulfamethoxazole 80mg/trimethoprim 16mg/ml injection (SMX/TMP) (updated) 8/5/2010, Propofol Injection 10mg/ml, 20ml 25s, 50ml 20s, 100ml 10s (updated) 8/4/2010"; arnews[3] += " Publ.Date : Thu, 02 Sep 2010 13:41:00 -0400"; arnews[3] += " "; arnews[4]="Newly Added Guidance Documents "; arnews[4] += ""; arnews[4] += " Publ.Date : Thu, 02 Sep 2010 09:04:00 -0400"; arnews[4] += " "; arnews[5]="Drugs@FDA Data Files "; arnews[5] += "Data files updated through September 1, 2010."; arnews[5] += " Publ.Date : Wed, 01 Sep 2010 13:25:00 -0400"; arnews[5] += " "; arnews[6]="National Drug Code Directory "; arnews[6] += "The National Drug Code has been updated with data through September 1, 2010."; arnews[6] += " Publ.Date : Wed, 01 Sep 2010 12:56:00 -0400"; arnews[6] += " "; arnews[7]="FDA Drug Safety Communication: Increased risk of death with Tygacil (tigecycline) compared to other antibiotics used to treat similar infections "; arnews[7] += "[09-01-2010] The U.S. Food and Drug Administration (FDA) is reminding healthcare professionals of an increased mortality risk associated with the use of the intravenous antibacterial Tygacil (tigecycline) compared to that of other drugs used to treat a variety of serious infections."; arnews[7] += " Publ.Date : Wed, 01 Sep 2010 10:00:00 -0400"; arnews[7] += " "; arnews[8]="Potential Signals of Serious Risks/New Safety Information Identified from the Adverse Event Reporting System (AERS) "; arnews[8] += "One new report (April to June 2010) and seven updated reports"; arnews[8] += " Publ.Date : Fri, 27 Aug 2010 14:04:00 -0400"; arnews[8] += " "; arnews[9]="September 20, 2010: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement "; arnews[9] += "Advisory Committees (Drugs)"; arnews[9] += " Publ.Date : Fri, 27 Aug 2010 09:54:00 -0400"; arnews[9] += " "; arnews[10]="Warning Letters 2010 "; arnews[10] += "Letters added"; arnews[10] += " Publ.Date : Wed, 25 Aug 2010 13:42:00 -0400"; arnews[10] += " "; arnews[11]="FDA Drug Safety Communication: Ongoing Safety Review of Stalevo and possible increased cardiovascular risk "; arnews[11] += "[08-20-2010] The U.S. Food and Drug Administration (FDA) is evaluating clinical trial data that suggest patients taking Stalevo (a combination of carbidopa/levodopa and entacapone) may be at an increased risk for cardiovascular events (heart attack, stroke, and cardiovascular death) compared to those taking carbidopa/levodopa (sold as the combination product, Sinemet)."; arnews[11] += " Publ.Date : Mon, 23 Aug 2010 10:43:00 -0400"; arnews[11] += " "; arnews[12]="FDA Drug Safety Communication: New boxed warning for severe liver injury with arthritis drug Arava (leflunomide) "; arnews[12] += "[07-13-2010] The U.S. Food and Drug Administration (FDA) is adding information on severe liver injury to the Boxed Warning of Arava (leflunomide) ? a drug used to treat rheumatoid arthritis - to highlight the risk of severe liver injury in patients using this drug and how this risk may be reduced."; arnews[12] += " Publ.Date : Fri, 20 Aug 2010 13:03:00 -0400"; arnews[12] += " "; arnews[13]="FDA Drug Safety Communication: Aseptic meningitis associated with use of Lamictal (lamotrigine) "; arnews[13] += "[08-12-2010] The U.S. Food and Drug Administration (FDA) is informing the public that Lamictal (lamotrigine)?, a medication commonly used for seizures in children two years and older, and bipolar disorder in adults, can cause aseptic meningitis."; arnews[13] += " Publ.Date : Mon, 16 Aug 2010 15:17:00 -0400"; arnews[13] += " "; arnews[14]="Additions/Deletions for Prescription and OTC Drug Product Lists "; arnews[14] += "The list has been updated through May 2010."; arnews[14] += " Publ.Date : Fri, 13 Aug 2010 12:05:00 -0400"; arnews[14] += " "; arnews[15]="Orange Book Zip File "; arnews[15] += "July 2010 Orange Book data files, zip format."; arnews[15] += " Publ.Date : Fri, 13 Aug 2010 12:00:00 -0400"; arnews[15] += " "; arnews[16]="FDA Drug Safety Communication: Ongoing safety review of Evamist (estradiol transdermal spray) and unintended exposure of children and pets to topical estrogen "; arnews[16] += "[07-29-2010] The U.S. Food and Drug Administration (FDA) is reviewing reports of adverse effects from Evamist in children who may have been unintentionally exposed to the drug through skin contact with women using this product."; arnews[16] += " Publ.Date : Wed, 11 Aug 2010 10:45:00 -0400"; arnews[16] += " "; arnews[17]="FDA Drug Info Rounds "; arnews[17] += "A new series of training videos for practicing clinical and community pharmacists"; arnews[17] += " Publ.Date : Mon, 09 Aug 2010 07:07:00 -0400"; arnews[17] += " "; totcount = 18; if (rnd) { for (x=0;x<=100;x++) { y=Math.round(Math.random()*totcount-0.5); z=x%totcount; tval=arnews[y]; arnews[y] = arnews[z]; arnews[z] = tval; } } for (x=0;x<=(totcount-1);x++) { document.write(arnews[x]); if (x != (totcount-1) ) document.write(" "); } document.write(" |